Delivery Order SPE2DB22D3501-SPE2DB26FTH58
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Naloxone HCL 4 mg nasal spray with a ceiling value of $1,100.49. This firm fixed-price delivery order, with an ultimate completion date of June 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made on...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $4,507.14 for Naloxone HCL 4 mg nasal spray on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price delivery order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in open federal...
- The Defense Logistics Agency awarded a delivery order valued at $7,640.38 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's critical role as a pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Naloxone HCL 4 mg nasal spray in a quantity of 2 units. This contract is valued at $1,135.68 with a firm fixed price structure and an ultimate completion date of September 2, 2025. The award was competitively procured with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Naloxone HCL 4 mg nasal spray with a ceiling value of $10,635.64. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 6, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Naloxone HCL 4 mg nasal spray in two-count units, with a ceiling value of $3,813.36. This is a firm fixed-price, non-set-aside contract with a completion date of September 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,237.02 to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Naloxone HCL 4 mg nasal spray (2-spray units). This is a firm fixed-price, non-set-aside contract with a completion date of October 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. This award is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,033.92 firm fixed price delivery order for Naloxone HCL 4 mg nasal spray on October 22, 2025, with an ultimate completion date of October 23, 2025. This competitive award, which carries no set-aside designation, represents a child contract action under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's headquarters location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,519.77 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-count units) on August 18, 2025, with completion targeted for August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework. Performance will be executed from the company's Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded a $1,653.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Naloxone HCL 4 mg nasal spray (2-count units). The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by August 5, 2025, and will be performed at the awardee's Conshohocken, Pennsylvania location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTH58Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Naloxone HCL 4 mg nasal spray with a ceiling value of $2,206.28. This is a firm fixed-price delivery order with an ultimate completion date of October 31, 2025, issued on a non-set-aside basis through competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a comprehensive global pharmaceutical support vehicle, the SPE2DX contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, syringes, and medical devices across multiple therapeutic domains. AmerisourceBergen, as a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills critical medical procurement needs for the Defense Health Agency and other federal healthcare systems through this versatile contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 10/30/25 |